San Francisco
FivePrime Therapeutics will sublease an entire floor in the new 190,000-sf J. David Gladstone Institutes building at Mission Bay in San Francisco. The Gladstone building was dedicated on December 6, 2004. The facility will enable FivePrime to develop new protein and antibody therapeutics utilizing an accelerated drug discovery approach. FivePrime will relocate its South San Francisco operations to the Gladstone building in San Francisco, a city which has a payroll tax exemption for biotech companies.
